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Reporting guidelines
To ensure thoroughness of reporting, authors of Scientific Reports are strongly encouraged to make use of the following guidelines, if applicable, when preparing manuscripts: 
Dual-use research of concern
Openness is recognized as a priority when making decisions regarding scientific publishing. Advances in molecular and cellular biology, genetics, microbiology, and other life sciences have made it increasingly possible to manipulate aspects of biological systems to better understand healthy states and mechanisms of disease. However, these advances have also increased the potential that information, products, or technologies resulting from life sciences research may be misused for harmful purposes. The US National Science Advisory Board for Biosecurity (http://osp.od.nih.gov/officebiotechnology-activities/biosecurity/nsabb) has proposed the following definition for dual-use research:
Dual-use research of concern is research that, based on current understanding, can be reasonably anticipated to provide knowledge, products, or technologies that could be directly misapplied by others to pose a threat to public health, safety, agricultural crops and other plants, animals, the environment, or material.
Accordingly, the JAVMA has adopted the following policy regarding assessment of submitted manuscripts with potential dual-use content:
 Any manuscript submitted for publication that raises concerns regarding dual-use potential will be subject to editorial review to determine the risks and benefits to the scientific community and to the public at large that may result from publication. The AVMA scientific editors maintain a strong commitment against withholding scientific or other information unless there are compelling reasons to do so.  The scientific editors reserve the right to seek special external review of these manuscripts from individuals with technical and biosecurity expertise to assist their decision.  Authors and reviewers are expected to alert the AVMA scientific editors when submitting or reviewing manuscripts with dual-use potential.  The final decision for publication as well as the means of communicating manuscripts with dual-use potential will be made by the editor-in-chief. An accompanying editorial may be published.
Scientific misconduct
The JAVMA strongly supports and upholds the code of conduct espoused by the international Committee on Publication Ethics (COPE) to promote integrity in the conduct and reporting of research. The Journal views gravely instances of scientific misconduct, which COPE defines as "the intention to cause others to regard as true that which is not." Such misconduct includes but is not limited to data fabrication or falsification, deceptive image manipulation, and plagiarism. In signing the Copyright Assignment Agreement and Authorship Form, authors attest that their works are original and free of scientific misconduct.
The JAVMA is ethically obliged to investigate all suspicions or allegations of scientific misconduct, including plagiarism. Therefore, authors are expected to know and understand the definition of plagiarism as well as the consequences. The JAVMA considers plagiarism the intentional or unintentional use of another's ideas or words as one's own, without attribution to the original source. Such use can range from copying of brief passages from previous publications (with or without changing a few words) to copying of entire portions of text, data, or both.
Detection of plagiarism and other instances of scientific misconduct will result in notification of the primary author, the coauthors, and possibly the author's institution, depending on the extent of misconduct and nature of the deception (eg, intentional, reckless, or negligent). Further sanctions for misconduct detected prior to publication will depend on the author's response to the allegations and may range from admonition by the editor to rejection of the manuscript, barring of the author(s) and their institution from future considerations, referral to the author's institution for further disciplinary action, and informing of other editors and the indexing authorities. For misconduct detected after publication, these sanctions can extend to retraction of the report, with full explanation of the reason, and reporting to other authorities.
MANUSCRIPT CATEGORIES
Authors may submit manuscripts for publication in the Views, Veterinary Medicine Today, and Scientific Reports sections of the journal.
Views
The Views section is a forum for exchange of ideas and includes:  Letters to the Editor  Commentaries  Viewpoint articles Letters to the editor-Readers who submit letters to the editor must limit them to 500 words (longer letters will be condensed as needed) and 6 references. Letters must be original and cannot have been published or submitted for publication elsewhere. Not all letters are published; all letters accepted for publication are subject to editing. Those pertaining to anything published in the JAVMA should be received within 1 month after the date of publication of the material to which they refer. Submission via email (JournalLetters@avma.org) is encouraged; authors should give their full contact information including address, daytime telephone number, fax number, and email address. Letters containing defamatory, libelous, or malicious statements will not be published, nor will letters representing attacks on or attempts to demean veterinary societies or their committees or agencies.
Commentaries-Commentaries represent opinionbased articles that relate to any aspect of the veterinary medical profession. Opinions expressed should be focused and clearly presented. The text should generally be less than 1,500 words. References should be limited, and tables and figures should generally not be included. These manuscripts are typically not sent for external peer review.
Viewpoint articles-Viewpoint articles describe an important issue in clinical medicine, public health, or biomedical research, generally espousing or promoting a particular viewpoint. They should be scholarly, thorough, and well-referenced. Maximum length is typically 5,000 words. Figures and tables may be included as necessary. Viewpoint articles are typically sent for external peer review, with reviewers specifically asked to comment on the overall importance of the topic to the veterinary profession, whether statements of fact in the manuscript are adequately referenced, whether any pertinent references have been omitted, and whether any aspects of the issue have been overemphasized or underemphasized. Authors are allowed to express opinions in Viewpoint articles, and manuscripts do not necessarily have to be balanced or dispassionate. However, authors should clearly indicate when they are stating an opinion versus established fact and should provide a cogent, logical defense of their viewpoint.
Veterinary Medicine Today
The Veterinary Medicine Today section promotes continuing education through didactic exercises, case discussions, and updates on clinical topics. Not every feature is published in every issue. Authors who wish to contribute a manuscript to the following features, which are published with the cooperation of various veterinary specialty organizations, should consult the instructions for those features: Authors who wish to contribute a manuscript to another feature in this section should refer to recent issues of the JAVMA that contain that feature for general format. Other features that are not affiliated with a specialty organization and to which any author may submit include:
Scientific Reports
The Scientific Reports section contains reports of important original research and critical reviews and includes:
Manuscripts based on original research in any area of veterinary medicine will be considered for publication as Original Studies. Generally, such manuscripts will describe studies involving animals with naturally occurring diseases or studies involving the evaluation of case records accumulated over a specific period (ie, case series). However, other types of original research (eg, surveys of people or evaluations of biological samples) will be considered, depending on the extent to which they add to the existing knowledge regarding veterinary medicine or the veterinary profession.
Manuscripts that describe features of 1 or more clinical cases will be considered for publication as Clinical Reports.
Concise, critical reviews concerning subject areas in which important advances have been made during the past 5 years and that contain information that has, or will have, clinical applications will be considered for publication as Review Articles.
For scientific manuscripts, preference is accorded to those that have immediate clinical or practical value. Note that reports of prospective or retrospective case series must include a meaningful statement of purpose, clinically relevant data, and clinically useful conclusions or interpretations derived directly from evaluation of the cases described. Authors should consult the guidance for reporting case series (www.avma.org/ News/Journals/Documents/JAVMA%20Guidance%20for %20Case%20Series%20Reporting.pdf) when preparing these reports. Except for rare conditions, case series reports should contain information on at least 10 animals.
MANUSCRIPT PREPARATION
Authors should pay close attention to the following guidelines for manuscript preparation and format. Manuscripts that are not prepared in accordance with these guidelines will be returned to the authors for amendment and resubmission.
Format
Manuscripts (including footnotes, references, figure legends, appendices, and tables) should be prepared with the following attributes:  8.5 X 11-inch (or A4) page size  Double-space typed  12-point Times New Roman font  1-inch (2.5-cm) margins  Left justification  Sequential line numbering
Organization and contents
Manuscripts should be organized as follows:
 Title page  Structured abstract (when applicable; letters to the editor, commentaries, viewpoint articles, feature submissions, and review articles do not have a structured abstract)  Abbreviations list (when applicable
Title page
The title page must include the manuscript title and the first name, middle initial, and last name of each author, along with each author's professional degree and highest earned academic degree (eg, MS or PhD, MPVM). Academic degrees lower than the bachelor's degree (eg, associate degrees), specialty board certifications, fellowship designations, and honorary degrees should not be listed; a bachelor's degree should be listed only if it is the author's only degree. Professional affiliations of the authors at the time of the study should be indicated. If an author's affiliation has changed since the study was performed, the author's new affiliation should be identified as well. Finally, the name and email address of the corresponding author must also be included on the title page.
Structured abstract
With the exception of review articles, all manuscripts submitted for consideration as a Scientific Report must include a structured abstract of 250 or fewer words.
For an Original Study, the structured abstract must include the following headings: 
Abbreviations list
All abbreviations except for standard abbreviations (see www.avma.org/News/Journals/Documents/AVMAJournals-Style-Standard-Abbreviations.pdf for full list) and units of measure should be listed in alphabetical order at the beginning of the manuscript text (after the Structured Abstract and before the introductory section), along with their definitions. These abbreviations should then be used without expansion in the text, figures, appendices, and tables, except at the start of a sentence, in which case the expanded term should be used.
Text
The text for an Original Study begins with an introductory section (which does not have a heading) and then is organized under the following headings:
 Materials and Methods

 Results
 Discussion
The introductory section should supply sufficient pertinent background information to allow readers to understand and interpret the results. It must include the rationale for the study, a clear statement of the purpose of the study, and the investigators' hypothesis or hypotheses. It generally should be brief (2 to 3 paragraphs is often sufficient) and is not intended to be a thorough review of all information on a subject.
The Materials and Methods section should describe the experimental design in sufficient detail to allow others to reproduce the study. A subsection detailing statistical methods used to summarize data, evaluate data distributions, and test hypotheses, along with a statement regarding the level of significance used for hypothesis testing, should be provided. Appendices and methods-related figures should be cited parenthetically. Products (including software), equipment, and drugs should be identified in the text by chemical or generic names or descriptions. A trade name may be included in a lettered footnote if that specific product, equipment, or drug was essential for the outcome. For all statistical tests, authors are required to indicate whether applicable test assumptions were met. When citing software products, a footnote should be used to cite the software (eg, PROC GLM, SAS, version 9.2, SAS Institute Inc, Cary, NC) and a reference should be used to cite a user's guide (eg, SAS/STAT 9.2 user's guide. Cary, NC: SAS Institute Inc, 2008;page number).
The Results section should provide data that are clearly and simply stated without discussion or conclusions. Tables and figures should be cited parenthetically. Authors should refrain from repeating within the text data that are also presented in tables. Authors of manuscripts reporting gene sequences should submit those sequences to an appropriate data bank.
The Discussion section should focus on findings in the manuscript and should be brief (generally no more than 2,000 words), containing only discussion that is necessary for the interpretation of findings. The Discussion should concentrate mainly on what is known in nonhuman animals, with less emphasis on what is known in humans. It should not contain any subheadings.
For case series reports, formatting of the titles differs slightly from that for titles of other original studies. Specifically, the title must include the number of cases and the interval during which cases were treated. The general format is as follows: Behavioral modification for treatment of separation anxiety in dogs: 223 cases (2005) (2006) (2007) (2008) (2009) (2010) . In addition, the Materials and Methods section should typically begin with the subheadings Case selection criteria and Medical records review.
For Clinical Reports, the text should begin with the signalment (eg, age, sex, body weight, and breed) of the animal or animals, followed by a chronological description of pertinent aspects of the diagnostic examination, treatment, and outcome, and should end with a brief discussion. When more than 1 animal is involved, a representative of the group can be described in detail, with important differences among animals addressed separately. For reports in which there are 3 or fewer animals, pertinent abnormal findings should be summarized in the text. For 4 or more animals, a single table that provides a summary of pertinent abnormal findings may be accommodated, provided that such findings are not repeated in the text.
In general, Scientific Reports should be brief and focus on the main issues. Although there are no word limits for Scientific Reports in the JAVMA, the main text (ie, all text other than the acknowledgments, footnotes, references, figure legends, appendices, and tables) for most manuscript should consist of no more than 3,000 to 4,000 words. Manuscripts that are excessively long may be returned for removal of nonessential information.
Acknowledgments
The Acknowledgments section is where information on sources of funding and support and conflicts of interest must be listed, along with any disclaimers, any acknowledgments of individuals who made important contributions to the study but did not meet the criteria for authorship, and any previous presentations of the findings at scientific meetings. In addition, for studies involving multiple institutions, a statement indicating where the work was done may be included, if applicable. For information on listing sources of funding and support and conflicts of interest, see the editorial policies on Funding and support and Conflicts of interest and financial disclosures.
The Acknowledgments section should be used to identify specific individuals who had an important role in or made important contributions to the study but who do not meet the criteria for authorship. In general, this includes individuals who contributed intellectually to the study or report but whose contributions do not justify authorship, individuals who provided technical assistance (eg, individuals who performed special tests or research), and individuals who assisted with the statistical analyses.
The Acknowledgments section should not be used simply as a method of expressing gratitude to individuals who had a minor role in the study. The acknowledgments should not include individuals whose only contribution to the study or report involved the routine performance of their normal job duties and who did not provide any unusual or extraordinary intellectual contribution or technical expertise to the study. Acknowledgments of nonspecific groups (eg, the intensive care unit technicians) and unidentifiable groups (eg, the anonymous contributors or study participants) are not allowed.
Individuals named in the acknowledgments must have given their permission to the authors to be listed, because readers may infer their endorsement of the data and conclusions.
Footnotes
Footnotes are to be used when referencing each of the following types of information:
 Abstracts  Conference presentations  Online databases  Personal communications  Products, drugs, equipment, and other materials  Statistical and computer software  Theses and dissertations  Other unpublished materials (eg, preliminary reports)
Specific products, equipment, or drugs should be included in the footnotes only if they were essential to the outcome of the report or study. Products, equipment, and drugs that are commonly used materials in veterinary medicine need not be footnoted.
Footnotes should be cited in the text as superscript letters and listed alphabetically after the Acknowledgments section and before the references. If more than 26 footnotes are required, continue the sequence with double letters (eg, aa, bb, and cc). For products and equipment, provide complete information in the footnote, including manufacturer's name and location (ie, city, state, and country [if other than the United States]).
References
Authors bear primary responsibility for accuracy of all references. References must be limited to those that are necessary and must be cited in the text by superscript numbers in order of citation. Journal titles in the Reference section should be abbreviated in accordance with the National Library of Medicine (www.ncbi.nlm.nih.gov/nlmcatalog/journals) and Index Medicus (www2.bg.am.poznan.pl/czasopisma/medicus. php?lang=eng). For references with more than 3 authors, only the first 3 authors should be listed, followed by et al. The following is the style used for common types of references: 
Figures
Figures should be limited to those that reduce or clarify the text. Images of clinically normal animals are not usually required, nor are images of equipment unless the equipment has been set up in a special way and the setup is integral to the study. Text and symbols should be large enough that they will still be legible when the figure is reduced to 1 column in width during publication (in general, this means that all text and symbols must be at least 1.5 mm tall when the figure is reduced to 8 cm in width). Text labels should start with a capital letter (eg, Cranial vena cava).
To ensure high-quality reproduction, symbols used to represent data in graphs should be limited to white and black circles, triangles, and squares; axes should be labeled in Helvetica or Arial font. Keys to data symbols may be placed in a small box inserted into the unused portion of graphs. Symbols used in figures and tables should be assigned in the following order:
Photomicrographs and electron micrographs must include an internal scale marker. For figures that include multiple panels, each panel should be sequentially labeled with a capital letter in the same corner of each panel. If a figure contains 2 or more rows of panels, the letter labels should be applied sequentially from left to right in the first row, then from left to right in the second row, and so on.
For preparation of digital versions of figures, please see the section on preparation of electronic files for manuscript submission.
Figure legends must be provided at the end of the manuscript, after the references and before any appendices and tables. Sufficient information should be included to allow the figure to be understood without reference to the text. Abbreviations defined in the abbreviations list at the beginning of the text do not need to be expanded; however, newly introduced abbreviations in figures should be defined in the figure legend, in alphabetical order. When applicable, stains used for microscopic examination of specimens must be indicated in the legend as well as the scale of the marker bar (eg, H&E stain; bar = 100 µm). Figure legends for ECG traces must include the paper speed and scale (eg, Paper speed = 50 mm/s; 1 cm = 1 mV). Authors wishing to use any previously published figures must submit written permission from the copyright holder.
Appendices
Appendices may be provided when information pertaining to the Materials and Methods could be more succinctly and clearly summarized in tabular rather than narrative format. Examples of information that might lend itself to an appendix include scoring and classification rubrics; lists of nucleotide sequences; tabular summaries of complex treatment protocols; and compositions of diets or feedstuffs. Copies of questionnaires and surveys also qualify as appendix materials but should instead be submitted in pdf format for publication as online supplementary material. Tables  Tables are reserved for reporting of findings and not for describing the materials and methods. Submission of excessive tabular data is discouraged, and tables should be limited to those containing data important to understanding and interpreting results of the study. All tables should be placed at the end of the manuscript, after the figure legends. Authors will be asked to delete tables containing data that could be reported more succinctly in the text. Tables that focus solely on findings in individual animals rather than summary data from groups of animals are to be avoided. Authors wishing to use any previously published tables must submit written permission from the copyright holder.
For the order of symbol use in tables, please refer to the instructions for preparation of figures. To indicate significant differences between or among values in a row or column, symbols or superscript lowercase letters assigned in alphabetical order (a-z) may be used. If additional differentiation is needed (eg, if differences need to be reported in both rows and columns) and lowercase letters have already been used, superscript uppercase letters in alphabetical order (A-Z) may be used.
Supplementary materials
Additional materials that are not in themselves essential to the understanding of the article but provide an important expansion of the article contents may be submitted for publication as supplementary materials. Examples include extended descriptions of experimental methods or statistical analyses, extended bibliographies, additional supporting data or results (eg, tables and figures), reporting checklists, copies of survey instruments or questionnaires, handouts, forms, and multimedia representations (eg, video clips) of relevant content. All published supplementary materials are subject to copyright.
Supplementary materials must be useful to readers and relevant to the article; redundant and extraneous content will not be accepted. Whether supplementary materials will be accepted for publication is solely at the discretion of the editors. Supplementary materials accepted for publication will not appear in the printed version of the journal but will be posted on the journal's website. Ideally, supplementary materials will be sent with the manuscript to external reviewers for peer review. Whether supplementary materials have or have not undergone peer review will be indicated on the landing page where the supplemental materials are posted.
Supplementary materials should be prepared in compliance with the general guidelines for manuscript style. Although supplementary materials may undergo minor copy editing or formatting, they generally will not undergo the same substantive editing provided for manuscripts. Therefore, the authors are responsible for ensuring clarity and accuracy of the content as well as consistency with the printed version. Authors of manuscripts that are not written in their first language or that required substantial language translation in the writing process are encouraged to seek professional language correction or copyediting services prior to submission. Such services can aid with language, grammar, and style in scientific writing and can help ensure the manuscript content can be understood by editors and potential reviewers.
MANUSCRIPT STYLE
Abbreviations
Overuse of abbreviations can be confusing and frustrating for readers. In general, use of abbreviations other than standard abbreviations (see www.avma. org/News/Journals/Documents/AVMA-Journals-StyleStandard-Abbreviations.pdf for full list) and units of measure should be kept to a minimum.
In the Structured Abstract, a term should be abbreviated only if it is used at least 3 times in the Structured Abstract. The term must be expanded at first mention, with the abbreviation given in parentheses after the expanded term. Similarly, in the manuscript text, figures, appendices, and tables, a term should be abbreviated only if it is used at least 3 times.
Abbreviations used in the Structured Abstract must be defined again in the abbreviations list. All abbreviations should be derived directly from the word or words that make up the expanded term.
Abbreviations that appear only in the figures or tables should be defined in the figure or table legend. Except for the abbreviations ELISA, ACTH, EDTA, DNA, and RNA, abbreviations should not be used in titles.
Products, equipment, drugs, and other materials
All materials used in the study or referred to in the manuscript should generally be identified by chemical or generic names or descriptions. A trade name may be included in a lettered footnote if that specific product, equipment, or drug was essential for the outcome. Trademark and similar proprietary symbols are not needed.
MANUSCRIPT SUBMISSION
Manuscripts must be submitted online at http://mc.manuscriptcentral.com/avma.
Electronic file specifications
Manuscripts must be in Microsoft Word format (.doc or .docx) or rich text format (.rtf). Tables should be included at the end of the manuscript in the same electronic file; however, if necessary, they can be saved as separate files.
Figures
All figures should be saved as separate electronic files with the name of the figure used as the file name (eg, Figure 1) ; figures should not be embedded in the manuscript. Gray scale or black and white should be used; color should be used only when important information would otherwise be lost (eg, when certain tissue-staining patterns are poorly visible in gray scale or when a color-flow Doppler ultrasonogram is provided). For figures that include multiple panels, each panel should be sequentially labeled with a capital letter in the same corner of each panel. If a figure contains 2 or more rows of panels, the letter labels should be applied sequentially from left to right in the first row, then from left to right in the second row, and so on. Simple figures such as line drawings, bar graphs, and line graphs prepared in Excel should be saved and submitted as Excel files (.xls or .xlsx). Line drawings and graphs that were not prepared in Excel should be submitted as .TIF files; however, .JPG, .GIF, .EPS, and .BMP files are also acceptable. Figures created with software programs that use proprietary graphic formats (eg, SigmaPlot or Statistix) cannot be used; most such software programs have the capability to save figures in one of the aforementioned formats. Minimum resolution for line drawings and charts is 300 dots per inch.
Digital images (eg, photographs, photomicrographs, and radiographs) should be provided at a minimum resolution of 300 dots per inch. Images that are not available in a digital format should be scanned on a flatbed scanner, also at a resolution of at least 300 dots per inch. Files should be saved as .TIF files; however, .JPG, .GIF, .EPS, and .BMP files are also acceptable. Color figures should be submitted in CMYK, rather than RGB, format to prevent color shift during production.
Additional required materials
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